Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS

Pyott David E I exercised options for 201 Tarsus Pharmaceuticals, Inc. shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 17, 2026

On Sep 15, 2026, Pyott David E I (Director) exercised options for 201 Tarsus Pharmaceuticals, Inc. shares, leaving 9,575 shares. Filed Sep 17, 2026 (Form 4).

Options exercised
201 shares
Holding after
9,575 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockOption exercise2019,575Indirect

Source

View original at SEC

Related